The offer by United Drug to acquire all of the share capital issued by Dublin Drug has been approved by the London and Dublin stock exchanges. The approval comes after 4,126,531 acceptances were received. The acceptances represent 93 per cent of Dublin Drug's present issued share capital. As the 80 per cent condition has been met, the acceptance of the offer has become unconditional.

The listing now goes ahead, subject to allotment of the 3,657,888 ordinary United Drug shares to be issued under the terms of the offer.